$377 Million is the total value of DAFNA Capital Management LLC's 80 reported holdings in Q3 2021. The portfolio turnover from Q2 2021 to Q3 2021 was 21.4% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| STXS | STEREOTAXIS INC | $73,601,000 | -44.2% | 13,680,554 | 0.0% | 19.53% | -29.2% | |
| BPMC | Sell | BLUEPRINT MEDICINES CORP | $21,273,000 | +16.3% | 206,911 | -0.5% | 5.64% | +47.6% |
| FATE | Buy | FATE THERAPEUTICS INC | $20,410,000 | -25.2% | 344,360 | +9.5% | 5.42% | -5.1% |
| BHVN | Sell | BIOHAVEN PHARMACTL HLDG CO L | $12,238,000 | +34.0% | 88,100 | -6.4% | 3.25% | +70.0% |
| DRNA | Buy | DICERNA PHARMACEUTICALS INC | $11,843,000 | -37.9% | 587,456 | +15.0% | 3.14% | -21.2% |
| IDYA | Buy | IDEAYA BIOSCIENCES INC | $11,727,000 | +68.4% | 460,061 | +38.7% | 3.11% | +113.7% |
| DXCM | DEXCOM INC | $11,560,000 | +28.1% | 21,138 | 0.0% | 3.07% | +62.4% | |
| MORF | MORPHIC HLDG INC | $10,278,000 | -1.3% | 181,467 | 0.0% | 2.73% | +25.2% | |
| NRIX | NURIX THERAPEUTICS INC | $9,177,000 | +12.9% | 306,320 | 0.0% | 2.44% | +43.2% | |
| KRTX | Buy | KARUNA THERAPEUTICS INC | $9,124,000 | +51.0% | 74,585 | +40.7% | 2.42% | +91.7% |
| NBIX | Buy | NEUROCRINE BIOSCIENCES INC | $8,119,000 | +13.3% | 84,655 | +14.9% | 2.15% | +43.7% |
| SAGE | Buy | SAGE THERAPEUTICS INC | $7,989,000 | -17.4% | 180,306 | +5.9% | 2.12% | +4.8% |
| ARNA | ARENA PHARMACEUTICALS INC | $7,123,000 | -12.7% | 119,615 | 0.0% | 1.89% | +10.8% | |
| IBB | ISHARES TR NASDAQ BIOTECHetf | $6,613,000 | -1.2% | 40,900 | 0.0% | 1.75% | +25.3% | |
| CSII | Buy | CARDIOVASCULAR SYS INC | $6,361,000 | -0.4% | 193,741 | +29.4% | 1.69% | +26.4% |
| CYTK | New | CYTOKINETICS INC | $6,255,000 | – | 175,000 | +100.0% | 1.66% | – |
| XENE | XENON PHARMACEUTICALS INC | $6,212,000 | -17.9% | 406,535 | 0.0% | 1.65% | +4.1% | |
| AFMD | AFFIMED N V | $5,963,000 | -27.3% | 964,857 | 0.0% | 1.58% | -7.8% | |
| RVMD | REVOLUTION MEDICINES INC | $5,770,000 | -13.3% | 209,731 | 0.0% | 1.53% | +10.0% | |
| FSTX | Sell | F-STAR THERAPEUTICS INC | $5,079,000 | -17.2% | 693,785 | -2.9% | 1.35% | +5.0% |
| ATRC | Sell | ATRICURE INC | $5,010,000 | -31.0% | 72,029 | -21.3% | 1.33% | -12.5% |
| OTIC | OTONOMY INC | $4,568,000 | -13.9% | 2,379,392 | 0.0% | 1.21% | +9.2% | |
| RCUS | Buy | ARCUS BIOSCIENCES INC | $4,313,000 | +31.2% | 123,700 | +3.3% | 1.14% | +66.5% |
| GLPG | GALAPAGOS NVspon adr | $4,086,000 | -23.6% | 77,675 | 0.0% | 1.08% | -3.1% | |
| ARAY | ACCURAY INC | $3,720,000 | -12.6% | 941,800 | 0.0% | 0.99% | +10.9% | |
| RADIUS HEALTH INCnote 3.000% 9/0 | $3,630,000 | -2.2% | 4,000,000 | 0.0% | 0.96% | +24.1% | ||
| ISEE | Buy | IVERIC BIO INC | $3,514,000 | +209.6% | 216,351 | +20.2% | 0.93% | +293.2% |
| KALV | Buy | KALVISTA PHARMACEUTICALS INC | $3,301,000 | +127.3% | 189,163 | +212.2% | 0.88% | +188.2% |
| AERI | AERIE PHARMACEUTICALS INC | $3,295,000 | -28.8% | 289,040 | 0.0% | 0.87% | -9.7% | |
| FSII | Sell | FS DEVELOPMENT CORP II | $2,985,000 | -0.3% | 299,950 | -0.0% | 0.79% | +26.5% |
| ACET | ADICET BIO INC | $2,950,000 | -23.8% | 376,281 | 0.0% | 0.78% | -3.3% | |
| RIGL | Buy | RIGEL PHARMACEUTICALS INC | $2,937,000 | +177.3% | 809,000 | +231.6% | 0.78% | +252.5% |
| MRUS | Sell | MERUS N V | $2,903,000 | -12.7% | 131,949 | -16.4% | 0.77% | +10.6% |
| VKTX | VIKING THERAPEUTICS INC | $2,810,000 | +4.9% | 447,400 | 0.0% | 0.75% | +33.2% | |
| VERO | Sell | VENUS CONCEPT INC | $2,794,000 | -24.2% | 1,113,228 | -6.1% | 0.74% | -3.9% |
| TPTX | Sell | TURNING POINT THERAPEUTICS I | $2,787,000 | -25.3% | 41,952 | -12.3% | 0.74% | -5.4% |
| KDMN | Sell | KADMON HLDGS INC | $2,740,000 | +79.4% | 314,561 | -20.3% | 0.73% | +127.9% |
| MREO | MEREO BIOPHARMA GROUP PLCads | $2,726,000 | -23.7% | 1,126,613 | 0.0% | 0.72% | -3.2% | |
| ETNB | Buy | 89BIO INC | $2,481,000 | +13.9% | 126,652 | +8.8% | 0.66% | +44.3% |
| PRQR | Sell | PROQR THERAPEUTICS N V | $2,481,000 | -64.3% | 296,383 | -71.3% | 0.66% | -54.8% |
| ALEC | New | ALECTOR INC | $2,451,000 | – | 107,412 | +100.0% | 0.65% | – |
| KNTE | Buy | KINNATE BIOPHARMA INC | $2,451,000 | +93.4% | 106,453 | +95.6% | 0.65% | +145.3% |
| NTUS | NATUS MED INC | $2,399,000 | -3.5% | 95,653 | 0.0% | 0.64% | +22.3% | |
| ITOS | New | ITEOS THERAPEUTICS INC | $2,243,000 | – | 83,061 | +100.0% | 0.60% | – |
| STIM | Buy | NEURONETICS INC | $2,058,000 | -49.4% | 313,717 | +23.6% | 0.55% | -35.8% |
| IPSC | CENTURY THERAPEUTICS INC | $2,013,000 | -14.2% | 80,000 | 0.0% | 0.53% | +8.8% | |
| CBAY | Buy | CYMABAY THERAPEUTICS INC | $1,914,000 | -14.0% | 524,286 | +2.7% | 0.51% | +9.2% |
| HOOK | HOOKIPA PHARMA INC | $1,897,000 | -35.7% | 322,124 | 0.0% | 0.50% | -18.5% | |
| KURA | Buy | KURA ONCOLOGY INC | $1,889,000 | +8.4% | 100,829 | +20.7% | 0.50% | +37.6% |
| MGNX | New | MACROGENICS INC | $1,885,000 | – | 90,000 | +100.0% | 0.50% | – |
| COGT | COGENT BIOSCIENCES INC | $1,880,000 | +3.7% | 223,554 | 0.0% | 0.50% | +31.7% | |
| PHAS | PHASEBIO PHARMACEUTICALS INC | $1,875,000 | -16.4% | 603,042 | 0.0% | 0.50% | +6.0% | |
| MEIP | MEI PHARMA INC | $1,769,000 | -3.2% | 641,000 | 0.0% | 0.47% | +22.8% | |
| BWAY | BRAINWAY LTDsponsored ads | $1,612,000 | -21.0% | 200,000 | 0.0% | 0.43% | +0.2% | |
| STRO | SUTRO BIOPHARMA INC | $1,606,000 | +1.6% | 85,000 | 0.0% | 0.43% | +29.1% | |
| New | FIELD TRIP HEALTH LTD | $1,565,000 | – | 340,900 | +100.0% | 0.42% | – | |
| IFRX | INFLARX NV | $1,554,000 | -12.8% | 600,000 | 0.0% | 0.41% | +10.5% | |
| SNDX | Sell | SYNDAX PHARMACEUTICALS INC | $1,542,000 | -39.2% | 80,702 | -45.4% | 0.41% | -22.8% |
| ATHA | ATHIRA PHARMA INC | $1,510,000 | -8.4% | 160,983 | 0.0% | 0.40% | +16.2% | |
| NGM | Buy | NGM BIOPHARMACEUTICALS INC | $1,376,000 | +129.0% | 65,485 | +114.7% | 0.36% | +189.7% |
| AERIE PHARMACEUTICALS INCnote 1.500%10/0 | $1,375,000 | -8.1% | 1,500,000 | 0.0% | 0.36% | +16.6% | ||
| MRSN | Buy | MERSANA THERAPEUTICS INC | $1,323,000 | -24.1% | 140,263 | +9.4% | 0.35% | -3.6% |
| ASLN | Buy | ASLAN PHARMACEUTICALS LTDads | $1,304,000 | -41.7% | 732,500 | +8.1% | 0.35% | -26.1% |
| BOLT | BOLT BIOTHERAPEUTICS INC | $1,265,000 | -18.2% | 100,000 | 0.0% | 0.34% | +4.0% | |
| NXTC | NEXTCURE INC | $1,237,000 | -16.0% | 183,491 | 0.0% | 0.33% | +6.5% | |
| CGEN | COMPUGEN LTDord | $1,203,000 | -27.9% | 201,502 | 0.0% | 0.32% | -8.6% | |
| ALPN | Sell | ALPINE IMMUNE SCIENCES INC | $1,190,000 | +16.7% | 111,501 | -1.6% | 0.32% | +48.4% |
| HARP | HARPOON THERAPEUTICS INC | $831,000 | -43.0% | 105,163 | 0.0% | 0.22% | -27.9% | |
| LVTX | Buy | LAVA THERAPEUTICS NV | $825,000 | -44.1% | 139,332 | +2.7% | 0.22% | -29.1% |
| MASI | MASIMO CORP | $812,000 | +11.7% | 3,000 | 0.0% | 0.22% | +41.4% | |
| INFI | Sell | INFINITY PHARMACEUTICALS INC | $808,000 | -41.2% | 236,160 | -48.6% | 0.21% | -25.4% |
| LRMR | Sell | LARIMAR THERAPEUTICS INC | $744,000 | -1.6% | 64,487 | -16.2% | 0.20% | +24.7% |
| GNFT | GENFIT S Aads | $698,000 | -2.5% | 188,549 | 0.0% | 0.18% | +23.3% | |
| INGN | INOGEN INC | $646,000 | -33.9% | 15,000 | 0.0% | 0.17% | -16.6% | |
| SRGA | SURGALIGN HOLDINGS INC | $632,000 | -21.6% | 579,710 | 0.0% | 0.17% | -0.6% | |
| PHVS | New | PHARVARIS N V | $622,000 | – | 35,074 | +100.0% | 0.16% | – |
| MDGL | MADRIGAL PHARMACEUTICALS INC | $447,000 | -18.0% | 5,600 | 0.0% | 0.12% | +4.4% | |
| ANNX | New | ANNEXON INC | $434,000 | – | 23,296 | +100.0% | 0.12% | – |
| RDUS | RADIUS HEALTH INC | $180,000 | -31.8% | 14,500 | 0.0% | 0.05% | -12.7% | |
| VBLT | Sell | VASCULAR BIOGENICS LTD | $113,000 | -84.6% | 55,000 | -82.1% | 0.03% | -80.5% |
| CNTB | Exit | CONNECT BIOPHARMA HLDGS LTDads | $0 | – | -8,000 | -100.0% | -0.03% | – |
| SCPH | Exit | SCPHARMACEUTICALS INC | $0 | – | -38,891 | -100.0% | -0.05% | – |
| APLS | Exit | APELLIS PHARMACEUTICALS INC | $0 | – | -12,703 | -100.0% | -0.17% | – |
| ASND | Exit | ASCENDIS PHARMA A Ssponsored adr | $0 | – | -7,137 | -100.0% | -0.20% | – |
| CFMS | Exit | CONFORMIS INC | $0 | – | -1,300,000 | -100.0% | -0.31% | – |
| ACRS | Exit | ACLARIS THERAPEUTICS INC | $0 | – | -100,000 | -100.0% | -0.37% | – |
| RDHL | Exit | REDHILL BIOPHARMA LTDsponsored ads | $0 | – | -455,933 | -100.0% | -0.66% | – |
| CARA | Exit | CARA THERAPEUTICS INC | $0 | – | -315,000 | -100.0% | -0.94% | – |
| LMNX | Exit | LUMINEX CORP | $0 | – | -139,091 | -100.0% | -1.07% | – |
| TBIO | Exit | TRANSLATE BIO INC | $0 | – | -376,993 | -100.0% | -2.17% | – |
| TBPH | Exit | THERAVANCE BIOPHARMA INC | $0 | – | -732,345 | -100.0% | -2.22% | – |
Other managers
Other managers that, in addition to the filing manager(s), that filed the EDGAR filing(s):
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2021-11-15
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| STEREOTAXIS INC | 42 | Q3 2023 | 27.6% |
| ATRICURE INC | 42 | Q3 2023 | 11.4% |
| MASIMO CORPORATION | 42 | Q3 2023 | 1.8% |
| ASCENDIS PHARMA A S SPONSORED | 34 | Q3 2023 | 4.5% |
| AERIE PHARMACEUTICALS INC | 33 | Q3 2022 | 4.2% |
| GALAPAGOS NV-SPON ADR | 33 | Q3 2023 | 3.8% |
| XENON PHARMACEUTICALS INC | 33 | Q3 2023 | 3.6% |
| NEUROCRINE BIOSCIENCES INC | 32 | Q3 2023 | 2.9% |
| JOHNSON AND JOHNSON | 32 | Q1 2021 | 1.2% |
| ISHARES TR NASDQ BIOTECH | 30 | Q3 2023 | 4.0% |
View DAFNA Capital Management LLC's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| Stereotaxis, Inc. | March 08, 2018 | 13,680,554 | 23.4% |
| SUNESIS PHARMACEUTICALS INC | February 14, 2018 | 983,000 | 2.9% |
| SUNESIS PHARMACEUTICALS INC | February 14, 2017 | 1,133,583 | 5.4% |
| WINDTREE THERAPEUTICS INC /DE/ | February 14, 2017 | 208,333 | 2.4% |
| ANAVEX LIFE SCIENCES CORP.Sold out | February 16, 2016 | 0 | 0.0% |
| DISCOVERY LABORATORIES INC /DE/ | February 16, 2016 | 10,658,699 | 9.2% |
| PRECISION OPTICS CORPORATION, INC. | February 13, 2015 | 311,537 | 5.0% |
| TearLab Corp | February 14, 2013 | 939,239 | 3.2% |
| VIKING SYSTEMS INC | February 14, 2012 | 3,781,468 | 5.2% |
View DAFNA Capital Management LLC's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G | 2024-02-14 |
| 13F-HR | 2023-11-14 |
| 13F-HR | 2023-08-14 |
| 13F-HR | 2023-05-15 |
| SC 13G/A | 2023-02-14 |
| 13F-HR | 2023-02-14 |
| 13F-HR | 2022-11-14 |
| 13F-HR | 2022-08-15 |
View DAFNA Capital Management LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.